Titlesort descending Credit Type Event date Cost
APPOS Richmond 2025
    • 10.00 AMA PRA Category 1 Credit™
    • 10.00 ANCC
    • 10.00 ACPE Pharmacy
    • 2.25 Pharmacology
 Live 04/11/2025 - 4:00am PDT $65.00
APPOS Salt Lake City 2025
    • 11.50 AMA PRA Category 1 Credit™
    • 11.50 ANCC
    • 11.50 ACPE Pharmacy
    • 2.50 Pharmacology
 Live 06/06/2025 - 6:00am PDT $65.00
APPOS San Francisco 2025
    • 9.25 AMA PRA Category 1 Credit™
    • 9.25 ANCC
    • 9.25 ACPE Pharmacy
    • 4.25 Pharmacology
 Live 08/15/2025 - 7:00am PDT $65.00
APPOS Scottsdale 2025
    • 9.25 AMA PRA Category 1 Credit™
    • 9.25 ANCC
    • 9.25 ACPE Pharmacy
    • 2.75 Pharmacology
 Live 08/15/2025 - 7:00am PDT $65.00
APPOS Seattle 2025
    • 9.25 AMA PRA Category 1 Credit™
    • 9.25 ANCC
    • 9.25 ACPE Pharmacy
    • 5.00 Pharmacology
 Live 05/16/2025 - 7:00am PDT $65.00
APPOS Washington DC 2025
    • 9.50 AMA PRA Category 1 Credit™
    • 9.50 ANCC
    • 9.50 ACPE Pharmacy
    • 2.75 Pharmacology
 Live 05/02/2025 - 4:00am PDT $65.00
Best Practices for Opioid Pain Management in Patients with Cancer
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 ANCC
 Enduring $0.00
Bispecific Therapy in Cancer Treatment
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 ANCC
 Enduring $0.00
Cardiotoxicity in Oncology Patients: Risks, Diagnostics, and Interventions
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 ANCC
 Enduring $0.00
Current Treatment Paradigms for Head and Neck Cancers
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 ANCC
 Enduring $0.00
Examining and Addressing Disparities in Multiple Myeloma Treatment & Outcomes (On-Demand)
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 ANCC
 Enduring $0.00
Expanding the Role of Immunotherapy: New Regimens for Use in the Adjuvant and Neoadjuvant Settings
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 ANCC
 Enduring $0.00
Genomic Profiling for Clinical Decision Making in Hematologic Malignancies
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 ANCC
    • 0.50 Pharmacology
 Live 02/06/2025 - 8:55pm PST $0.00
Hitting the Target: Updates and Review in Genotype Directed Therapy for Non-Small Cell Lung Cancer
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 ANCC
 Enduring $0.00
Improving Outcomes in Advanced Prostate Cancer (On-Demand)
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 ANCC
    • 0.50 Pharmacology
 Enduring $0.00

Pages